Abstracts
Showing 852 abstracts.
Citation
Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D., Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Douglas J. Manion, M.D., F.R.C.P. Safety, Pharmacokinetics and Antiviral Effect of Efavirenz (EFV) Liquid Suspension in Combination with Nelfinavir (NLF) and Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Children.Citation
Lameck Chinula, Sean S. Brummel, Lauren Ziemba, Katie McCarthy, Benjamin Johnston, Benjamin Johnston, Nahida Chakhtoura, Patrick Jean-Philippe, Lynda Stranix-Chibanda, Violet Korutaro, Haseena Cassim, Lee Fairlie, Gaerolwe Masheto, Paul Sax, Judith S. Currier, Shahin Lockman. Safety/Efficacy of DTG vs EFV, TDF vs TAF in Pregnancy/Postpartum: IMPAACT 2010 Trial. Presented at: CROI 2021; 2021 Mar 10.Conference
CROI 2021
Study
IMPAACT 2010
Citation
Kelong Han, Navin Goyal, Susan Ford, Amy Cheung, Lionel Tan, Cindy McCoig, Parul Patel, Edmund Capparelli, Brookie Best, Mark Marzinke, Conn Harrington, David Izard, Jenny Huang, Mark Baker. Selection of Cabotegravir Dosing Regimens for HIV Treatment and Pre-exposure Prophylaxis (PrEP) in Adolescents by Leveraging Adult Data. Presented at: International Workshop on HIV Pediatrics.Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2017
Citation
GR Campbell, RS Bruckman, SA Spector, YL Chu. Selectively eliminating HIV latently-infected cells without viral reactivation. Presented at: CROI 2015; 2015 Feb 25.Conference
CROI 2015
Citation
Neetal Nevrekar, Kevin Butler, David E. Shapiro, Patience Atuhaire, Taha E Taha, Bonus Makanani, Lameck Chinula, Maxie Owor, Daya Moodley, Tsungai Chipato, Pat Flynn, Judy Currier, Mary Glenn Fowler, Amita Gupta, Nishi Suryavanshi. Self-Reported Antiretroviral Adherence: Association with Maternal Viral Load Suppression in HIV-1-Infected Postpartum Women in Promoting Maternal and Infant Survival Everywhere (PROMISE): randomized, open label trial in Sub-Saharan Africa and India. Presented at: IAS 2021.Conference
IAS 2021
Study
1077BF, 1077FF
Citation
Mona Rigaud, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Adriana Weinberg, M.D., Philip LaRussa, M.D., Terence Fenton, Ed.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Patrick Jean-Philippe, M.D., Bonnie Zimmer, B.S., Dorothy Smith, M.S., C.P.N.P. Serological responses to recall and neoantigens in severely immunocompromised HIV-infected children initiating HAART enrolled in PACTG 1006. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1006
Citation
N Hanan, M Paul, Y Huo, E Capparelli, S Kapetanovic, JL Ariansen, E Smith, P Brouwers, B Best. Sertraline pharmacokinetics in HIV-infected on ARV and uninfected youth. Presented at: CROI 2017; 2017 Feb 16.Conference
CROI 2017
Study
P1080
Citation
Severe immunodeficiency in children starting ART in low-, middle- and high-income countries. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.Conference
20th Conference on Retroviruses and Opportunistic Infections
Citation
Sexual maturation in perinatally HIV-infected and HIV-exposed youth in the era of combination antiretroviral treatment.Citation
Andres F. Camacho-Gonzalez , Miriam C. Chernoff, Paige L. Williams, Ann Chahroudi , James M. Oleske , Rana Chakraborty , Shirley Traite , Murli U. Purswani , Mark J. Abzug , IMPAACT P1074 Study Team. Sexually Transmitted Infections in Youth with Controlled and Uncontrolled HIV. Presented at: CROI 2015; 2015 Feb 25.Conference
CROI 2015
Study
P1074